Cite
HARVARD Citation
Shimamura, S. et al. (2021). Significant therapeutic effectiveness of durvalumab after chemoradiotherapy for a patient with post‐operative recurrent pulmonary pleomorphic carcinoma. Respirology case reports. 9 (6), p. n/a. [Online].